Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 5/20 | 0.77 |
| ▸ | MET | P08581 | 8/20 | 0.73 |
| ▸ | MAOB | P27338 | 1/20 | 0.73 |
| ▸ | CA12 | O43570 | 2/20 | 0.66 |
| ▸ | CA4 | P22748 | 2/20 | 0.66 |
| ▸ | CA6 | P23280 | 2/20 | 0.66 |
| ▸ | CA5A | P35218 | 2/20 | 0.66 |
| ▸ | CA7 | P43166 | 2/20 | 0.66 |
| ▸ | CA9 | Q16790 | 2/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.66 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.66 |
| ▸ | TTR | P02766 | 1/20 | 0.66 |
| ▸ | HTR7 | P34969 | 1/20 | 0.66 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.64 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2793041 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 | |
| SCHEMBL10608577 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 | |
| SCHEMBL6353292 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 | |
| SCHEMBL22462703 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 | |
| SCHEMBL11930638 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 | |
| SCHEMBL19369627 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 | |
| SCHEMBL23861277 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 | |
| SCHEMBL21001085 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 | |
| SCHEMBL21001086 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 | |
| SCHEMBL21034324 | 1.00 | APP (0.77) | APPMETMAOBCA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024105703-A1 | NOVEL OPHTHALMIC FORMULATION | FERTIS INDIA PVT LTD (IN) | 2024-05-23 | — | — | WO | claimed |
| US-6162422-A | Method of reducing or preventing malodour | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| WO-2000001359-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | UNILEVER PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| EP-0742012-A2 | Pharmaceutical composition containing substance inhibiting HSP47 production | Kureha Chemical Industry Co., Ltd. (JP) | 1996-11-13 | — | — | EP | disclosed |